Table of Contents 1 Influenza Therapeutics Market Overview 1.1 Product Overview and Scope of Influenza Therapeutics 1.2 Classification of Influenza Therapeutics by Types 1.2.1 Global Influenza Therapeutics Revenue Comparison by Types (2019-2024) 1.2.2 Global Influenza Therapeutics Revenue Market Share by Types in 2018 1.2.3 Vaccines 1.2.4 Drugs 1.3 Global Influenza Therapeutics Market by Application 1.3.1 Global Influenza Therapeutics Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospitals 1.3.3 Clinic 1.3.4 Others 1.4 Global Influenza Therapeutics Market by Regions 1.4.1 Global Influenza Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Influenza Therapeutics Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Influenza Therapeutics Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Influenza Therapeutics Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Influenza Therapeutics Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Influenza Therapeutics Status and Prospect (2014-2024) 1.5 Global Market Size of Influenza Therapeutics (2014-2024) 2 Company Profiles 2.1 Glaxosmithkline PLC 2.1.1 Business Overview 2.1.2 Influenza Therapeutics Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Glaxosmithkline PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.2 Mitsubishi Tanabe Pharma Corporation 2.2.1 Business Overview 2.2.2 Influenza Therapeutics Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.3 Chiron Corporation 2.3.1 Business Overview 2.3.2 Influenza Therapeutics Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Chiron Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.4 Astrazeneca PLC 2.4.1 Business Overview 2.4.2 Influenza Therapeutics Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Astrazeneca PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.5 Abbott Laboratories 2.5.1 Business Overview 2.5.2 Influenza Therapeutics Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Abbott Laboratories Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.6 Biocryst Pharmaceuticals, Inc. 2.6.1 Business Overview 2.6.2 Influenza Therapeutics Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.7 Protein Sciences Corporation 2.7.1 Business Overview 2.7.2 Influenza Therapeutics Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Protein Sciences Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.8 Daiichi Sankyo Co., Ltd. 2.8.1 Business Overview 2.8.2 Influenza Therapeutics Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.9 CSL Limited 2.9.1 Business Overview 2.9.2 Influenza Therapeutics Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 CSL Limited Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.10 Nanotherapeutics Inc. 2.10.1 Business Overview 2.10.2 Influenza Therapeutics Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Nanotherapeutics Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.11 Roche Holding AG 2.11.1 Business Overview 2.11.2 Influenza Therapeutics Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Roche Holding AG Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.12 Sinovac Biotech Ltd. 2.12.1 Business Overview 2.12.2 Influenza Therapeutics Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Sinovac Biotech Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.13 Sanofi SA 2.13.1 Business Overview 2.13.2 Influenza Therapeutics Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Sanofi SA Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 2.14 Shionogi & Co., Ltd. 2.14.1 Business Overview 2.14.2 Influenza Therapeutics Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Shionogi & Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) 3 Global Influenza Therapeutics Market Competition, by Players 3.1 Global Influenza Therapeutics Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Influenza Therapeutics Players Market Share 3.2.2 Top 10 Influenza Therapeutics Players Market Share 3.3 Market Competition Trend 4 Global Influenza Therapeutics Market Size by Regions 4.1 Global Influenza Therapeutics Revenue and Market Share by Regions 4.2 North America Influenza Therapeutics Revenue and Growth Rate (2014-2019) 4.3 Europe Influenza Therapeutics Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Influenza Therapeutics Revenue and Growth Rate (2014-2019) 4.5 South America Influenza Therapeutics Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Influenza Therapeutics Revenue and Growth Rate (2014-2019) 5 North America Influenza Therapeutics Revenue by Countries 5.1 North America Influenza Therapeutics Revenue by Countries (2014-2019) 5.2 USA Influenza Therapeutics Revenue and Growth Rate (2014-2019) 5.3 Canada Influenza Therapeutics Revenue and Growth Rate (2014-2019) 5.4 Mexico Influenza Therapeutics Revenue and Growth Rate (2014-2019) 6 Europe Influenza Therapeutics Revenue by Countries 6.1 Europe Influenza Therapeutics Revenue by Countries (2014-2019) 6.2 Germany Influenza Therapeutics Revenue and Growth Rate (2014-2019) 6.3 UK Influenza Therapeutics Revenue and Growth Rate (2014-2019) 6.4 France Influenza Therapeutics Revenue and Growth Rate (2014-2019) 6.5 Russia Influenza Therapeutics Revenue and Growth Rate (2014-2019) 6.6 Italy Influenza Therapeutics Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Influenza Therapeutics Revenue by Countries 7.1 Asia-Pacific Influenza Therapeutics Revenue by Countries (2014-2019) 7.2 China Influenza Therapeutics Revenue and Growth Rate (2014-2019) 7.3 Japan Influenza Therapeutics Revenue and Growth Rate (2014-2019) 7.4 Korea Influenza Therapeutics Revenue and Growth Rate (2014-2019) 7.5 India Influenza Therapeutics Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Influenza Therapeutics Revenue and Growth Rate (2014-2019) 8 South America Influenza Therapeutics Revenue by Countries 8.1 South America Influenza Therapeutics Revenue by Countries (2014-2019) 8.2 Brazil Influenza Therapeutics Revenue and Growth Rate (2014-2019) 8.3 Argentina Influenza Therapeutics Revenue and Growth Rate (2014-2019) 8.4 Colombia Influenza Therapeutics Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Influenza Therapeutics by Countries 9.1 Middle East and Africa Influenza Therapeutics Revenue by Countries (2014-2019) 9.2 Saudi Arabia Influenza Therapeutics Revenue and Growth Rate (2014-2019) 9.3 UAE Influenza Therapeutics Revenue and Growth Rate (2014-2019) 9.4 Egypt Influenza Therapeutics Revenue and Growth Rate (2014-2019) 9.5 Nigeria Influenza Therapeutics Revenue and Growth Rate (2014-2019) 9.6 South Africa Influenza Therapeutics Revenue and Growth Rate (2014-2019) 10 Global Influenza Therapeutics Market Segment by Type 10.1 Global Influenza Therapeutics Revenue and Market Share by Type (2014-2019) 10.2 Global Influenza Therapeutics Market Forecast by Type (2019-2024) 10.3 Vaccines Revenue Growth Rate (2014-2024) 10.4 Drugs Revenue Growth Rate (2014-2024) 11 Global Influenza Therapeutics Market Segment by Application 11.1 Global Influenza Therapeutics Revenue Market Share by Application (2014-2019) 11.2 Influenza Therapeutics Market Forecast by Application (2019-2024) 11.3 Hospitals Revenue Growth (2014-2019) 11.4 Clinic Revenue Growth (2014-2019) 11.5 Others Revenue Growth (2014-2019) 12 Global Influenza Therapeutics Market Size Forecast (2019-2024) 12.1 Global Influenza Therapeutics Market Size Forecast (2019-2024) 12.2 Global Influenza Therapeutics Market Forecast by Regions (2019-2024) 12.3 North America Influenza Therapeutics Revenue Market Forecast (2019-2024) 12.4 Europe Influenza Therapeutics Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Influenza Therapeutics Revenue Market Forecast (2019-2024) 12.6 South America Influenza Therapeutics Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Influenza Therapeutics Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Influenza Therapeutics Picture Table Product Specifications of Influenza Therapeutics Table Global Influenza Therapeutics and Revenue (Million USD) Market Split by Product Type Figure Global Influenza Therapeutics Revenue Market Share by Types in 2018 Figure Vaccines Picture Figure Drugs Picture Table Global Influenza Therapeutics Revenue (Million USD) by Application (2014-2024) Figure Influenza Therapeutics Revenue Market Share by Applications in 2018 Figure Hospitals Picture Figure Clinic Picture Figure Others Picture Table Global Market Influenza Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Influenza Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Influenza Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Influenza Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Influenza Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Influenza Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Influenza Therapeutics Revenue (Million USD) and Growth Rate (2014-2024) Table Glaxosmithkline PLC Basic Information, Manufacturing Base and Competitors Table Glaxosmithkline PLC Influenza Therapeutics Type and Applications Table Glaxosmithkline PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Mitsubishi Tanabe Pharma Corporation Basic Information, Manufacturing Base and Competitors Table Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Type and Applications Table Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Chiron Corporation Basic Information, Manufacturing Base and Competitors Table Chiron Corporation Influenza Therapeutics Type and Applications Table Chiron Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Astrazeneca PLC Basic Information, Manufacturing Base and Competitors Table Astrazeneca PLC Influenza Therapeutics Type and Applications Table Astrazeneca PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors Table Abbott Laboratories Influenza Therapeutics Type and Applications Table Abbott Laboratories Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Biocryst Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors Table Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Type and Applications Table Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Protein Sciences Corporation Basic Information, Manufacturing Base and Competitors Table Protein Sciences Corporation Influenza Therapeutics Type and Applications Table Protein Sciences Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Daiichi Sankyo Co., Ltd. Basic Information, Manufacturing Base and Competitors Table Daiichi Sankyo Co., Ltd. Influenza Therapeutics Type and Applications Table Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table CSL Limited Basic Information, Manufacturing Base and Competitors Table CSL Limited Influenza Therapeutics Type and Applications Table CSL Limited Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Nanotherapeutics Inc. Basic Information, Manufacturing Base and Competitors Table Nanotherapeutics Inc. Influenza Therapeutics Type and Applications Table Nanotherapeutics Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Roche Holding AG Basic Information, Manufacturing Base and Competitors Table Roche Holding AG Influenza Therapeutics Type and Applications Table Roche Holding AG Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Sinovac Biotech Ltd. Basic Information, Manufacturing Base and Competitors Table Sinovac Biotech Ltd. Influenza Therapeutics Type and Applications Table Sinovac Biotech Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Sanofi SA Basic Information, Manufacturing Base and Competitors Table Sanofi SA Influenza Therapeutics Type and Applications Table Sanofi SA Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Shionogi & Co., Ltd. Basic Information, Manufacturing Base and Competitors Table Shionogi & Co., Ltd. Influenza Therapeutics Type and Applications Table Shionogi & Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2017-2018) Table Global Influenza Therapeutics Revenue (Million USD) by Players (2014-2019) Table Global Influenza Therapeutics Revenue Share by Players (2014-2019) Figure Global Influenza Therapeutics Revenue Share by Players in 2017 Figure Global Influenza Therapeutics Revenue Share by Players in 2018 Figure Global Top 5 Players Influenza Therapeutics Revenue Market Share in 2018 Figure Global Top 10 Players Influenza Therapeutics Revenue Market Share in 2018 Figure Global Influenza Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Influenza Therapeutics Revenue (Million USD) by Regions (2014-2019) Table Global Influenza Therapeutics Revenue Market Share by Regions (2014-2019) Figure Global Influenza Therapeutics Revenue Market Share by Regions (2014-2019) Figure Global Influenza Therapeutics Revenue Market Share by Regions in 2018 Figure North America Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Europe Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure South America Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Influenza Therapeutics Revenue and Growth Rate (2014-2019) Table North America Influenza Therapeutics Revenue by Countries (2014-2019) Table North America Influenza Therapeutics Revenue Market Share by Countries (2014-2019) Figure North America Influenza Therapeutics Revenue Market Share by Countries (2014-2019) Figure North America Influenza Therapeutics Revenue Market Share by Countries in 2018 Figure USA Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Canada Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Mexico Influenza Therapeutics Revenue and Growth Rate (2014-2019) Table Europe Influenza Therapeutics Revenue (Million USD) by Countries (2014-2019) Figure Europe Influenza Therapeutics Revenue Market Share by Countries (2014-2019) Figure Europe Influenza Therapeutics Revenue Market Share by Countries in 2018 Figure Germany Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure UK Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure France Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Russia Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Italy Influenza Therapeutics Revenue and Growth Rate (2014-2019) Table Asia-Pacific Influenza Therapeutics Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Influenza Therapeutics Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Influenza Therapeutics Revenue Market Share by Countries in 2018 Figure China Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Japan Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Korea Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure India Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Southeast Asia Influenza Therapeutics Revenue and Growth Rate (2014-2019) Table South America Influenza Therapeutics Revenue by Countries (2014-2019) Table South America Influenza Therapeutics Revenue Market Share by Countries (2014-2019) Figure South America Influenza Therapeutics Revenue Market Share by Countries (2014-2019) Figure South America Influenza Therapeutics Revenue Market Share by Countries in 2018 Figure Brazil Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Argentina Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Colombia Influenza Therapeutics Revenue and Growth Rate (2014-2019) Table Middle East and Africa Influenza Therapeutics Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Influenza Therapeutics Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Influenza Therapeutics Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Influenza Therapeutics Revenue Market Share by Countries in 2018 Figure Saudi Arabia Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure UAE Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Egypt Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure Nigeria Influenza Therapeutics Revenue and Growth Rate (2014-2019) Figure South Africa Influenza Therapeutics Revenue and Growth Rate (2014-2019) Table Global Influenza Therapeutics Revenue (Million USD) by Type (2014-2019) Table Global Influenza Therapeutics Revenue Share by Type (2014-2019) Figure Global Influenza Therapeutics Revenue Share by Type (2014-2019) Figure Global Influenza Therapeutics Revenue Share by Type in 2018 Table Global Influenza Therapeutics Revenue Forecast by Type (2019-2024) Figure Global Influenza Therapeutics Market Share Forecast by Type (2019-2024) Figure Global Vaccines Revenue Growth Rate (2014-2019) Figure Global Drugs Revenue Growth Rate (2014-2019) Table Global Influenza Therapeutics Revenue by Application (2014-2019) Table Global Influenza Therapeutics Revenue Share by Application (2014-2019) Figure Global Influenza Therapeutics Revenue Share by Application (2014-2019) Figure Global Influenza Therapeutics Revenue Share by Application in 2018 Table Global Influenza Therapeutics Revenue Forecast by Application (2019-2024) Figure Global Influenza Therapeutics Market Share Forecast by Application (2019-2024) Figure Global Hospitals Revenue Growth Rate (2014-2019) Figure Global Clinic Revenue Growth Rate (2014-2019) Figure Global Others Revenue Growth Rate (2014-2019) Figure Global Influenza Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Influenza Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Influenza Therapeutics Revenue Market Share Forecast by Regions (2019-2024) Figure North America Influenza Therapeutics Revenue Market Forecast (2019-2024) Figure Europe Influenza Therapeutics Revenue Market Forecast (2019-2024) Figure Asia-Pacific Influenza Therapeutics Revenue Market Forecast (2019-2024) Figure South America Influenza Therapeutics Revenue Market Forecast (2019-2024) Figure Middle East and Africa Influenza Therapeutics Revenue Market Forecast (2019-2024)

Glaxosmithkline PLC Mitsubishi Tanabe Pharma Corporation Chiron Corporation Astrazeneca PLC Abbott Laboratories Biocryst Pharmaceuticals, Inc. Protein Sciences Corporation Daiichi Sankyo Co., Ltd. CSL Limited Nanotherapeutics Inc. Roche Holding AG Sinovac Biotech Ltd. Sanofi SA Shionogi & Co., Ltd.